What does the evidence say about Resistant Dextrin Gut Microbiota Randomized Trial?

Updated October 2026

Quick Answer

Resistant Dextrin Gut Microbiota Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: It increased with the active supplementation and remained stable with the placebo, both in the entire population (5.5% vs.

Key Takeaways

  • 01It increased with the active supplementation and remained stable with the placebo, both in the entire population (5.5% vs. [Perreau C (2026)]
  • 02No treatment effect ( p > 0.05) was found on pH, SCFAs, IgA, stool consistency and frequency. [Perreau C (2026)]
  • 03Conclusion The tested resistant dextrin was effective in modulating the gut microbiota after four weeks of supplementation in healthy male volunteers, favoring the Parabacteroides genus and several related species (especially P. [Perreau C (2026)]
  • 04Background and objectives The average intake of dietary fibers known to beneficially modulate the gut microbiota is below recommendations in high-income countries. [Perreau C (2026)]
The current Migaku evidence database contains 2 reusable source documents for Resistant Dextrin Gut Microbiota Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - It increased with the active supplementation and remained stable with the placebo, both in the entire population (5.5% vs. [Perreau C (2026); evidence level 2] - No treatment effect ( p > 0.05) was found on pH, SCFAs, IgA, stool consistency and frequency. [Perreau C (2026); evidence level 2] - Conclusion The tested resistant dextrin was effective in modulating the gut microbiota after four weeks of supplementation in healthy male volunteers, favoring the Parabacteroides genus and several related species (especially P. [Perreau C (2026); evidence level 2] - Background and objectives The average intake of dietary fibers known to beneficially modulate the gut microbiota is below recommendations in high-income countries. [Perreau C (2026); evidence level 2] - Background/objectives Aging-related dysbiosis is associated with increased production of harmful gut-derived metabolites. [Yoshida K (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Resistant dextrin promotes beneficial fecal bacteria in high and low fiber diet populations: a randomized, double-blinded, controlled pilot study.
  2. Combined effects of resistant dextrin and inulin on the reduction of harmful metabolites during <i>in vitro</i> fecal fermentation in older adults.